DOI: 10.21276/ajptr
Fri, 24 May 2019

A Study of An Efficacy of Tacrolimus (Generic Form) In Renal Transplant Recipients

KhajaRamizuddinMahammad1*, Shiv ShankerPunna1, VenkataSravaniPolamraju1, SrikalaPatha2

1.Department of Pharmacy, Bharat Institute of Pharmacy, Jawaharlal Nehru Technological University, Andhra Pradesh, India

2.PharmD,Head of Department, Department of Pharmacy, Bharat Institute of Pharmacy, Jawaharlal Nehru Technological University, Andhra Pradesh, India


This study helps to determine the efficacy of tacrolimus (generic form) in renal transplant patients in India. To assess the efficacy of tacrolimus in renal transplant recipients by using graft survival rate (primary objective) and patient survival rate (secondary objective). This is a retrospective study involving collection of data from medical records of patients who underwent renal transplantation in between JUNE 2010-JUNE 2013 at a tertiary care hospital) in India. Study population involves 65 patients between age group of 10-60 years, Male and Female gender, patients receiving tacrolimus (generic form) in their immunosuppressive regimen. Exclusion criteria involved patients with hyperacute graft dysfunction, patients who did not receive tacrolimus as a part of immuno suppressive regimen. Tacrolimus was given in combination with mycophenolatemofetil, corticosteroids. Tacrolimus was given at a dose of 0.15 mg/kg and titrated based on the graft function, trough levels of tacrolimus and other parameters. Of 65 patients,59 were men and 6 were women.86% of patients received graft from living donor, where as 14 % of patients received from cadaveric donor. Graft survival rates for the 1st, 2nd, 3rd years of transplantation were found to be 93.84%,89.23%,87.68 %.Patient survival rate was 98.46% during the 1st year, and it remained same for the succeeding years with no loss of patient lives. The main limitations of this study are inadequate sample size and retrospective nature of study. Through this study, it was concluded that tacrolimus(generic form) demonstrated efficacy in majority of renal transplant patients in preventing graft rejection and maintained favorable function for a period of 3 years.

[PDF]   Viewed: 1044   Downloaded: 88
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter